Conference Coverage
June 27, 2025
TB Vaccination Could Enhance BCG Response in Patients With Non–Muscle-Invasive Bladder Cancer, Study Finds
EAU Congress 2025
June 27, 2025
Novel Strategy Could Help Recover Erectile Function Following Prostate Cancer Surgery
EAU Congress 2025
June 27, 2025
Radiotherapy Alone Following Radical Hysterectomy for Cervical Cancer: Should It Remain the Standard of Care?
SGO 2025 Annual Meeting on Womens Cancer
June 27, 2025
Study Shows Disparities in Diagnosing Endometrial Cancer in Women With Postmenopausal Bleeding
SGO 2025 Annual Meeting on Womens Cancer
June 27, 2025
Exploratory Post Hoc Analysis of DUO-E Reveals Olaparib’s Benefit in Endometrial Cancer Subsets
SGO 2025 Annual Meeting on Womens Cancer
June 27, 2025
In Case You Missed It: Abstracts on Novel Therapies in Gastrointestinal Cancers
2025 ASCO GI
June 27, 2025
Everolimus/Lanreotide vs Everolimus in Gastroenteropancreatic Neuroendocrine Tumors
2025 ASCO GI
June 27, 2025
Enfortumab Vedotin Plus Pembrolizumab Continues to Show Benefit in Metastatic Urothelial Carcinoma
2025 ASCO GU
June 27, 2025
Nivolumab Plus Cabozantinib Continues to Show Superior Long-Term Outcomes in Advanced Renal Cell Carcinoma
2025 ASCO GU
June 27, 2025
In Case You Missed It: Additional Studies of Interest From ASH 2024
2024 ASH Annual Meeting
June 27, 2025
Novel BTK and BCL2 Inhibitors Redefine CLL Treatment Across Front-Line and Relapsed Settings
2024 ASH Annual Meeting
June 26, 2025
Adding the Hepcidin Mimetic Rusfertide to the Standard of Care Yields Benefits in Polycythemia Vera
2025 ASCO Annual Meeting
June 25, 2025
Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K-Mutated Colorectal Cancer
2025 ASCO GI
June 25, 2025
Menopause Medication May Help to Prevent Invasive Breast Cancer, Study Finds
2025 ASCO Annual Meeting
June 25, 2025
Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy
2025 ASCO Annual Meeting
June 25, 2025
AACR 2025: Trends in Breast Cancer Incidence for Women Between the Ages of 20 and 49
2025 AACR Annual Meeting
June 19, 2025
Novel Tri-Specific Antibody Shows Efficacy and Safety in Refractory Myeloma
EHA 2025 Congress
June 19, 2025
Ropeginterferon Alfa-2b Outperforms Anagrelide as Second-Line Therapy for ET, Study Finds
EHA 2025 Congress
June 17, 2025
Early-Phase Trial Shows Activity and Safety of Zongertinib in Previously Treated HER2-Mutant NSCLC
2025 AACR Annual Meeting
June 16, 2025
AACR 2025: Zoldonrasib May Elicit Objective Responses in Patients With KRAS G12D–Mutated NSCLC
2025 AACR Annual Meeting
June 16, 2025
Revisiting Margin Width Guidelines for Ductal Carcinoma In Situ and the Role of Routine Reexcision
2025 ASBrS Annual Meeting
June 16, 2025
Combination of Weight Gain, Age at Pregnancy Could Increase Breast Cancer Risk
ECO 2025
June 13, 2025
Conundrums in Treating HER2-Positive Early Breast Cancer
2025 Miami Breast Cancer Conference
May 13, 2025
Revisiting Margin Width Guidelines for Ductal Carcinoma In Situ and the Role of Routine Reexcision
2025 ASBrS Annual Meeting
May 09, 2025
Is Active Monitoring a Safe Option for Patients With Ductal Carcinoma In Situ?
2025 Miami Breast Cancer Conference
May 01, 2025
DDW 2025: 20-Year Screening Program Drives Down Colorectal Cancer Cases, Deaths
DDW 2025
April 24, 2025
Study Finds Standard Chemoradiation Therapy Superior to Deintensification Approaches for HPV-Related Oropharyngeal Cancer
2024 ASTRO Annual Meeting
April 04, 2025
Local Excision May Be Feasible in Patients With Low Rectal Adenocarcinoma
2025 SSO Annual Meeting
March 26, 2025
Sex Differences in Waist Circumference vs BMI as Risk Factors for Obesity-Related Cancers
ECO 2025
March 19, 2025
Is Active Monitoring a Safe Option for Patients With Ductal Carcinoma In Situ?
2025 Miami Breast Cancer Conference
March 12, 2025
Moderate-to-Vigorous Physical Activity May Lower Risk of Cardiovascular Disease–Related Mortality in Women With a Cancer History
AHA EPI | Lifestyle Scientific Sessions 2025
January 28, 2025
Anatomic Lung Resection May Be Linked to Improved Survival in Early-Stage NSCLC
2025 STS Annual Meeting
January 23, 2025
Managing Comorbidities in Oncology: Practical Strategies for Optimized Patient Care
2024 JADPRO Live
January 21, 2025
ChatGPT Has Limitations in Clinical Utility for Colorectal Cancer but May Be Useful for Patient Education
2025 ASCO Gastrointestinal Cancers Symposium
January 07, 2025
Adjuvant Tamoxifen May Reduce Recurrence Risk for Patients With ‘Good-Risk’ DCIS Who Forgo Radiation
2024 SABCS
January 01, 2025
Daratumumab Induction Regimen in Transplant-Ineligible Patients Newly Diagnosed with Multiple Myeloma
2024 International Myeloma Society Annual Meeting
December 17, 2024
Managing Comorbidities in Oncology: Practical Strategies for Optimized Patient Care
2024 JADPRO Live
December 09, 2024
Loncastuximab Tesirine May Improve Outcomes in High-Risk Follicular Lymphoma, Marginal Zone Lymphoma
2024 ASH Annual Meeting
December 09, 2024
Adding Chemoradiation in Perioperative Gastric Cancer Treatment Improves Pathologic Response Rates Without Survival Benefit
ESMO Congress 2024
December 09, 2024
I-SPY2.2: Dato-DXd Plus Durvalumab Yields High Pathologic Response Rate in Breast Cancer Subset
ESMO Congress 2024
December 09, 2024
Understanding the Assessment and Treatment of High-Risk Myelofibrosis
2024 JADPRO Live
December 09, 2024
Updated Findings in Preventive Breast Cancer Vaccine Study
2024 SITC Annual Meeting
December 09, 2024
Study Evaluating Lung Cancer Screening Program Receives Margulis Award for Scientific Excellence
RSNA 2024 Annual Meeting
December 09, 2024
4-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC
IASLC 2024 Asia Conference on Lung Cancer
December 09, 2024
AI and the Future of Lung Cancer Screening: Still Room for Improvement
Quantitative Imaging Workshop XXI
December 06, 2024
Self-Pay, AI-Based Program May Help Boost Mammogram Findings
RSNA 2024 Annual Meeting
December 05, 2024
SITC: Study Finds IO102-IO103 Vaccine Plus Pembrolizumab Active in Patients With Non–Small Cell Lung Cancer
2024 SITC Annual Meeting
November 24, 2024
TROPION-Lung01 Update: Dato-DXd Shows Activity in Previously Treated Advanced Nonsquamous NSCLC
2024 IASLC WCLC
November 24, 2024
Use of Aumolertinib Extends Progression-Free Survival in Stage III EGFR-Mutated NSCLC
2024 IASLC WCLC
November 24, 2024
Impact of Food Insecurity on the Incidence of Hepatocellular Carcinoma
2024 AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
November 24, 2024
Exploring Issues in Oncofertility
FDA-ASCO Virtual Workshop: Measuring Toxicity in Reproductive Organs During Oncology Drug Development
November 24, 2024
Determining the Optimal First-Line Management of Advanced Classical Hodgkin Lymphoma
2024 NCCN Annual Congress: Hematologic Malignancies
November 19, 2024
Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC
IASLC 2024 Asia Conference on Lung Cancer
November 14, 2024
Exploring Issues in Oncofertility
FDA-ASCO Virtual Workshop: Measuring Toxicity in Reproductive Organs During Oncology Drug Development
November 14, 2024
From Gaps to Bridges: Cancer Care Rooted in Equity, Quality, and Value
2024 World Cancer Congress
November 08, 2024
Advancing Diversity, Equity, and Inclusion Through a Challenging Policy Landscape
NCCN Oncology Policy Summit
November 08, 2024
When Cancer and Cardiovascular Disease Intersect
2024 Global Cardio-Oncology Summit
November 08, 2024
Evolving Role of MRD Status in Multiple Myeloma
2024 International Myeloma Society Annual Meeting
November 07, 2024
When Cancer and Cardiovascular Disease Intersect
2024 Global Cardio-Oncology Summit
October 30, 2024
Acalabrutinib Plus Chemoimmunotherapy Improves Progression-Free Survival in Older Patients With Mantle Cell Lymphoma
European Hematology Association 2024 Congress
October 30, 2024
Glofitamab Combination Therapy Shows Survival Benefit in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
European Hematology Association 2024 Congress
October 28, 2024
Scientists Develop a ‘Digital Twin’ Model to Predict Cancer Treatment Responses
36th EORTC-NCI-AACR Symposium
October 28, 2024
Early Results Show Novel Agent Has Clinical Activity in FGFR3-Driven Advanced Bladder Cancer
36th EORTC-NCI-AACR Symposium
October 24, 2024
New Hope for Patients With HER2-Mutant NSCLC: Durable Responses to Two Novel Targeted Therapies
2024 IASLC WCLC
October 22, 2024
ACA May Increase Access to Colorectal Cancer Care Among Underserved Groups
2024 AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
October 21, 2024
Cancer Diagnoses May Be Linked to Lasting Financial Challenges
ACS Clinical Congress 2024
October 17, 2024
Advancing Diversity, Equity, and Inclusion Through a Challenging Policy Landscape
NCCN Oncology Policy Summit
October 09, 2024
Creating a Culture of Diversity, Equity, and Inclusion: Why It Matters Clinically and Ethically
NCCN Oncology Policy Summit
October 09, 2024
Study Finds Nearly $70 Billion in Socioeconomic Losses Across 11 Countries Attributable to Ovarian Cancer
2024 World Cancer Congress
October 03, 2024
Duration of Postmastectomy Radiation Therapy in Patients Planning Breast Reconstruction
2024 ASTRO Annual Meeting
October 02, 2024
Immunotherapy/Chemoradiotherapy for Patients With Limited-Stage Small Cell Lung Cancer
2024 ASTRO Annual Meeting
October 01, 2024
Pharmaceutical Industry Sponsors and Clinical Cancer Research in the United States
2024 ASCO Quality Care Symposium
October 01, 2024
New Gene Therapy for Retinitis Pigmentosa Shows Promise
American Academy of Ophthalmology annual meeting
October 01, 2024
Transformative Strategies in Ocular Oncology Presented at AAO 2024
American Academy of Ophthalmology annual meeting
September 30, 2024
Conversations Between Physicians and Older Patients About Physical Activity May Reduce Falls During Cancer Treatment
2024 ASCO Quality Care Symposium
September 27, 2024
Cisplatin Shortage Led to Treatment Alternatives for Head and Neck Cancer, Significantly Increasing Cost
2024 ASCO Quality Care Symposium
September 24, 2024
Phase III ALEXANDRA/IMpassion030: No Survival Benefit for Adjuvant Atezolizumab in Triple-Negative Breast Cancer
2024 European Breast Cancer Conference
September 24, 2024
Black Patients With Triple-Negative Breast Cancer May Be Less Likely to Receive Immunotherapy Compared With White Patients
2024 AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
September 20, 2024
Phase III CABINET Trial: Cabozantinib in Advanced Neuroendocrine Tumors
ESMO Congress 2024
September 17, 2024
Study Finds Nearly $70 Billion in Socioeconomic Losses Across 11 Countries Attributable to Ovarian Cancer
2024 World Cancer Congress
September 09, 2024
What Is the Better Target for Bispecific Antibodies in Multiple Myeloma: BCMA or GPRC5D?
2024 Debates and Didactics in Hematology and Oncology
September 09, 2024
Discontinuation of CML Therapy: Which Patients Are Ideal Candidates?
2024 Debates and Didactics in Hematology and Oncology
September 04, 2024
Use of Immune Checkpoint Inhibitors Under Study in High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer
2024 Miami Breast Cancer Conference
August 29, 2024
What Is the Better Target for Bispecific Antibodies in Multiple Myeloma: BCMA or GPRC5D?
2024 Debates and Didactics in Hematology and Oncology
August 28, 2024
Can a Blood Test Predict Obesity-Related Cancer Risk in Patients With Type 2 Diabetes?
European Association for the Study of Diabetes Annual Meeting 2024
August 26, 2024
BTK Degraders and CELMoDs: Novel Mechanisms Overcoming Resistance in Hematologic Malignancies
2024 Pan Pacific Lymphoma Conference
August 26, 2024
LIBRETTO-431 Trial Shows Selpercatinib Is Effective in East Asian Patients With RET Fusion–Positive Non–Small Cell Lung Cancer
2024 ASCO Breakthrough
August 26, 2024
Detecting Residual Disease After Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
2024 ASCO Breakthrough
August 22, 2024
BTK Degraders and CELMoDs: Novel Mechanisms Overcoming Resistance in Hematologic Malignancies
2024 Pan Pacific Lymphoma Conference
August 09, 2024
Gestational Diabetes and Risk for Breast Cancer
European Association for the Study of Diabetes Annual Meeting 2024
August 08, 2024
Extranodal Marginal Zone Lymphoma: Is Overtreatment Common?
2024 Pan Pacific Lymphoma Conference
August 06, 2024
Active Surveillance May Enable Patients With Esophageal Cancer to Delay or Avoid Surgery
2024 ASCO Breakthrough
August 01, 2024
New Genetic Test May Predict Response to Immunotherapy in Triple-Negative Breast Cancer
2024 European Breast Cancer Conference
August 01, 2024
Glofitamab Combination Therapy Shows Survival Benefit in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
European Hematology Association 2024 Congress
July 25, 2024
Triplet Combination Improves Survival in Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Third-Line Setting
2024 ASCO Annual Meeting
July 18, 2024
New Genetic Test May Predict Response to Immunotherapy in Triple-Negative Breast Cancer
2024 European Breast Cancer Conference
July 03, 2024
Oral SERDs Poised to Impact Treatment of Hormone Receptor–Positive Breast Cancer
2024 Miami Breast Cancer Conference
July 01, 2024
Interim Phase 1 HELIOS Trial Data of Axpaxli for NPDR Presented at ASRS
American Society of Retina Specialists annual meeting
July 01, 2024
Supplemental Injection Data From DAVIO 2 Trial of EYP-1901 Presented at ASRS
American Society of Retina Specialists annual meeting
June 25, 2024
Study Documents Decline in Reimbursements for Breast Cancer Surgery From 2003 to 2023
2024 American Society of Breast Surgeons Annual Meeting
June 18, 2024
Can FAP-Targeted Radioligand Therapy Benefit Patients With Advanced Sarcomas?
2024 SNMMI Annual Meeting
June 17, 2024
Chelating Agent May Reduce Toxicity Associated With PSMA Radiopharmaceutical Therapy
2024 SNMMI Annual Meeting
June 17, 2024
Pretargeted Dual-Isotope Radionuclide Therapy in Colorectal Cancer
2024 SNMMI Annual Meeting
June 14, 2024
Innovative Staging System for De Novo Metastatic Breast Cancer Validated Internationally
2024 Society of Surgical Oncology Annual Meeting
June 10, 2024
LEAP-001: Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets
SGO 2024 Annual Meeting on Womens Cancer
June 06, 2024
Study Finds Early Menopause May Be Linked to Greater Risk of Breast and Ovarian Cancers
ENDO 2024
June 05, 2024
Impact of High Blood Insulin Levels on Triple-Negative Breast Cancer Survival in Black Women
ENDO 2024
June 01, 2024
Antibody-Drug Conjugate Plus Checkpoint Inhibitor for PD-L1–Positive, HR-Positive/HER2-Negative Breast Cancer
2024 ASCO Annual Meeting
May 29, 2024
Innovative Staging System for De Novo Metastatic Breast Cancer Validated Internationally
2024 Society of Surgical Oncology Annual Meeting
May 24, 2024
NCCN Clinical Practice Guidelines in Oncology: 2024 Updates
2024 NCCN Annual Conference
May 24, 2024
Is a Test for Early Detection of Pancreatic Cancer on the Horizon?
AACR Annual Meeting 2024
May 24, 2024
Study Reveals Potential Overtreatment of DCIS in Older Women With Limited Life Expectancy
2024 Society of Surgical Oncology Annual Meeting
May 24, 2024
Novel Approaches Show Early Activity in Endocrine-Resistant Breast Cancer
2024 Miami Breast Cancer Conference
May 22, 2024
Survival Outcomes Following Adjuvant Therapy in Patients With Clinical T2N0 Rectal Adenocarcinoma
Digestive Disease Week 2024
May 13, 2024
Oral Rinse Could Provide Early Screening for Gastric Cancer
Digestive Disease Week 2024
May 13, 2024
Colorectal Cancer Incidence Is Rising Among Teenagers and Young Adults
Digestive Disease Week 2024
May 13, 2024
Celebrating Excellence: Matthijs Oudkerk, PhD, MD, MSc, Honored for Contributions to Cancer Prevention and Research
Quantitative Imaging Workshop XX
May 09, 2024
Bispecific Antibody Plus Chemotherapy Improves Survival in Patients With Gastric or Gastroesophageal Junction Cancer
AACR Annual Meeting 2024
May 07, 2024
Novel Urine Biomarker Test May Reduce Unnecessary Cystoscopies in Patients With Bladder Cancer
European Association of Urology Congress 2024
April 25, 2024
Novel MDM2 Inhibitor Shows Activity in Salivary Gland Cancers
2024 Multidisciplinary Head and Neck Cancers Symposium
April 22, 2024
Bispecific Immune Checkpoint Inhibitor Improves Survival in Patients With Gastric Cancer, Regardless of PD-L1 Status
AACR Annual Meeting 2024
April 12, 2024
Improving Adjuvant Treatment in Patients With Muscle-Invasive Urothelial Carcinoma
European Association of Urology Congress 2024
April 12, 2024
The Lancet Commission on Prostate Cancer: Strategies to Prepare for Predicted Increases in Disease Burden by 2040
European Association of Urology Congress 2024
April 08, 2024
Undocumented Cost-of-Care Discussions: A Missed Opportunity in Cancer Treatment
2023 ASCO Quality Care Symposium
April 05, 2024
Pembrolizumab May Improve Breast Cancer Outcomes Regardless of Age or Menopausal Status
2024 EBCC
March 22, 2024
Addition of Atezolizumab to Adjuvant Chemotherapy in Triple-Negative Breast Cancer
2024 EBCC
March 19, 2024
ChatGPT May Accurately Answer Common Patient Questions Regarding Gynecologic Cancer
SGO 2024 Annual Meeting on Womens Cancer
March 12, 2024
HPV-Associated Oropharyngeal Cancer: Intratreatment FDG-PET Response as a Biomarker for De-escalation of Radiotherapy
2024 Multidisciplinary Head and Neck Cancers Symposium
March 11, 2024
Olaparib Plus Abiraterone and Prednisone Improves Outcomes Over Single Agents in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
2024 ASCO GU Cancers Symposium
March 11, 2024
Studies Show Progress in Using ctDNA to Guide Colorectal Cancer Treatment
2024 ASCO GI Cancers Symposium
March 05, 2024
HPV-Associated Oropharyngeal Cancer: Adjuvant Treatment Deintensification
2024 Multidisciplinary Head and Neck Cancers Symposium
February 28, 2024
Patients With Advanced Breast Cancer May Gain Multiple Benefits From Exercise as Part of Palliative Care
2023 SABCS
February 28, 2024
NATALEE Trial: Long-Term Results on Ribociclib Combination Therapy in Early-Stage Breast Cancer
2023 SABCS
February 16, 2024
Personalized Ibrutinib-Plus-Venetoclax Therapy: New Treatment Standard for Chronic Lymphocytic Leukemia?
2023 ASH
February 15, 2024
Do Patients With Molecular MRD Detected After Colorectal Cancer Surgery Benefit From Adjuvant Chemotherapy?
2024 ASCO GI Cancers Symposium
January 30, 2024
Immune Checkpoint Inhibitor–Based Therapy May Have Comparative Efficacy in Black and White Patients With Metastatic Renal Cell Carcinoma
2024 ASCO GU Cancers Symposium
January 25, 2024
Integrated Medicine and Collaborative Care: Innovations in Cancer Treatment and Mental Health Care
2023 ASCO Quality Care Symposium
January 25, 2024
ALL in Adults: Trial Updates and Clinical Considerations for Selecting Consolidation Therapy
2023 NCCN Annual Congress: Hematologic Malignancies
January 03, 2024
Phase III Trial Shows Novel Four-Drug Regimen Improves Survival Outcomes in Extensive-Stage Small Cell Lung Cancer
IASLC 2023 WCLC
December 21, 2023
International Collaborative Research Efforts in Cardio-oncology: Focus on Basic and Translational Science
2023 Global Cardio-Oncology Summit
December 11, 2023
Antibody-Drug Conjugate Makes Progress as Second-Line Therapy for Advanced NSCLC
ESMO Congress 2023
December 11, 2023
Understanding the Treatment Options for PD-1–Refractory Melanoma
2023 Debates and Didactics in Hematology and Oncology Conference
November 27, 2023
INCREASE Trial: Immunotherapy Plus Chemoradiotherapy Doubles Complete Pathologic Response Rate in NSCLC
IASLC 2023 WCLC
November 22, 2023
Cardiac Imaging and Biomarkers for Patients Receiving Cancer Treatment: What Oncologists Need to Know
2023 Global Cardio-Oncology Summit
November 22, 2023
Adjuvant Everolimus Improves Recurrence-Free Survival in Very High–Risk Renal Cell Carcinoma
ESMO Congress 2023
November 17, 2023
Extensive-Stage Small Cell Lung Cancer: Triplet Combination vs Chemotherapy Alone
IASLC 2023 WCLC
November 08, 2023
Cabozantinib for Pretreated Patients With Advanced Neuroendocrine Tumors: CABINET Trial
ESMO Congress 2023
October 31, 2023
Patients With Newly Diagnosed NSCLC or Melanoma May Receive Limited Documentation of Treatment Cost Discussions
2023 ASCO Quality Care Symposium
October 25, 2023
NATALEE Trial: Quality of Life Maintained for Many Patients Treated With Ribociclib for Early-Stage Breast Cancer
2023 ESMO Virtual Plenary
October 25, 2023
The New Era of Perioperative Therapy in Non–Small Cell Lung Cancer
2023 Debates and Didactics in Hematology and Oncology Conference
October 17, 2023
Overall Survival in Two Monarch Trials of Abemaciclib in Advanced Breast Cancer
ESMO Congress 2022
October 17, 2023
Can Younger Women With Hormone Receptor–Positive Breast Cancer Safely Pause Endocrine Therapy to Pursue Pregnancy?
2022 San Antonio Breast Cancer Symposium
October 17, 2023
SOFT Analysis: Breast Cancer Index May Identify Which Patients Need Ovarian Suppression
2022 San Antonio Breast Cancer Symposium
October 17, 2023
Expert Point of View: Meritxell Bellet Ezquerra, MD, PhD, and Sung-Bae Kim, MD, PhD
ESMO Congress 2022
October 04, 2023
Using Recent Diagnostic Scans May Cut Time to Treatment for Patients Needing Urgent Palliative Radiotherapy
2023 ASTRO Annual Meeting
October 03, 2023
Stereotactic Radiotherapy for Patients With Primary RCC Unsuitable for Surgery: FASTRACK II
2023 ASTRO Annual Meeting
October 03, 2023
Liquid Biopsies May Be Predictive of Cancer Recurrence Following Chemoradiation in Patients With Cervical Cancer
2023 ASTRO Annual Meeting
September 26, 2023
Understanding the Treatment of Waldenström’s Macroglobulinemia
2023 Debates and Didactics in Hematology and Oncology Conference
September 20, 2023
CLL14: Long-Term Results of Fixed-Duration Venetoclax Plus Obinutuzumab in Elderly Patients With CLL
EHA Hybrid Congress 2023
September 14, 2023
Pembrolizumab Plus Chemoradiation Therapy Falls Short in Locally Advanced Head and Neck Cancer
ESMO Congress 2022
September 14, 2023
Cabozantinib Plus Atezolizumab Warrants Further Study in Treatment of Advanced Head and Neck Cancer
SITC 2022
September 11, 2023
Expert Point of View: Peter Paul Yu, MD, FACP, FASCO
2023 ASCO Breakthrough Meeting
August 24, 2023
Liquid Biopsy Assay Demonstrated Effectiveness in Early Cancer Detection in Asymptomatic Individuals in Vietnam
2023 ASCO Breakthrough Meeting
August 24, 2023
Noninvasive, Multitarget Stool DNA Methylation Assay Under Study in Early Detection of Multiple Gastrointestinal Cancers
2023 ASCO Breakthrough Meeting
August 18, 2023
CLEAR Trial: Continued Survival Benefit With First-Line Lenvatinib Plus Pembrolizumab in Advanced Kidney Cancer
2023 ASCO Annual Meeting
August 17, 2023
ZUMA-7: Primary Overall Survival Analysis Supports Axicabtagene Ciloleucel as Second-Line Therapy in Advanced Lymphoma
2023 ASCO Annual Meeting
August 15, 2023
CheckMate 274: Continued Disease-Free Survival Benefits With Adjuvant Nivolumab in High-Risk Urothelial Carcinoma
2023 ASCO Genitourinary Cancers Symposium
August 10, 2023
IMerge Trial: Use of Imetelstat Reduces Transfusion Dependence in Lower-Risk MDS
2023 ASCO Annual Meeting
July 24, 2023
Two Studies Highlight Benefits in Quality of Life and Symptom Management With Novel Treatments of Advanced Breast Cancer
ESMO Breast Cancer Annual Congress 2023
July 06, 2023
Two Studies of Atezolizumab-Based Regimens in Early-Stage, Triple-Negative and HER2-Positive Breast Cancers
ESMO Breast Cancer Annual Congress 2023
June 23, 2023
In Case You Missed It: Brief Highlights From Studies Presented During AACR 2023
AACR Annual Meeting 2023
June 15, 2023
Surveillance Mammography Rates After Breast Cancer Treatment Remain High, Irrespective of Life Expectancy
24th ASBrS Annual Meeting
June 15, 2023
Novel Hormone Receptor–Driven Therapies Tackling Endocrine Resistance in Breast Cancer
2023 Miami Breast Cancer Conference
June 09, 2023
HER3-Targeting Antibody-Drug Conjugates Show Encouraging Results in Breast Cancer Subtypes
ESMO Breast Cancer Annual Congress 2023
June 07, 2023
Amivantamab Shows Efficacy in Advanced NSCLC With EGFR Exon 20 Insertions
European Lung Cancer Congress 2023
June 07, 2023
CodeBreaK 200: Sotorasib Offers Improved Quality of Life for Patients With Previously Treated NSCLC
European Lung Cancer Congress 2023
May 19, 2023
NCCN Clinical Practice Guidelines in Oncology: 2023 Updates
NCCN 2023 Annual Conference
May 11, 2023
GOG 3026: Durable Responses With Ribociclib Plus Letrozole in Low-Grade Serous Ovarian Cancer
SGO 2023 Annual Meeting on Women’s Cancer
May 04, 2023
Emerging Success With Novel Targeted Therapies in Endocrine-Resistant Metastatic Breast Cancer
2023 Miami Breast Cancer Conference
May 01, 2023
Intraoperative vs Postoperative Lymph Node Pathology Evaluation in Patients With Breast Cancer Undergoing Mastectomy
24th ASBrS Annual Meeting
May 01, 2023
Does Surveillance Mammography Benefit Geriatric Patients With Breast Cancer?
24th ASBrS Annual Meeting
April 25, 2023
Early-Stage Triple-Negative Breast Cancer: Optimizing Therapy
2023 Miami Breast Cancer Conference
April 17, 2023
Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma
AACR Annual Meeting 2023
April 12, 2023
ELCC 2023: New Data on Amivantamab-vmjw in Patients With Advanced NSCLC and EGFR Exon 20 Insertion Mutations
European Lung Cancer Congress 2023
March 30, 2023
Time-Related and Financial Burdens May Impact Quality of Life for Patients With Gynecologic Cancer
SGO 2023 Annual Meeting on Women’s Cancer
March 29, 2023
Positive Outcomes Demonstrated in Patients With Ovarian Cancer Treated With Olaparib Prior to Surgical Intervention and Subsequent Chemotherapy
SGO 2023 Annual Meeting on Women’s Cancer
March 24, 2023
FORMULA-509: Intensified Postoperative Regimen May Be of Benefit in Subset of High-Risk Prostate Cancer
2023 ASCO Genitourinary Cancers Symposium
March 14, 2023
Novel Urine Test May Play a Role in Bladder Cancer Prediction
2023 EAU Annual Congress
March 14, 2023
New Technique May Reduce Postoperative Complications in Prostate Cancer Surgery
2023 EAU Annual Congress
March 13, 2023
PSMA-PET/CT May Help Improve Clinical Treatment of Prostate Cancer
2023 EAU Annual Congress
February 24, 2023
Expert Point of View: Imane H. El Dika, MD
2023 ASCO Gastrointestinal Cancers Symposium
February 16, 2023
Ruxolitinib Demonstrates Clinical Activity in a Phase II Trial of Chronic Myelomonocytic Leukemia
2022 ASH Annual Meeting and Exposition
February 16, 2023
CAR T-Cell Therapy vs Chemoimmunotherapy in Second-Line Treatment of Resistant Large B-Cell Lymphoma
2022 ASH Annual Meeting and Exposition
February 16, 2023
Expert Point of View: Alexey Danilov, MD, PhD
2022 ASH Annual Meeting and Exposition
February 13, 2023
Subset of Patients With Advanced Gastric Cancer May Benefit From Claudin18.2-Targeted Agent Zolbetuximab
2023 ASCO Gastrointestinal Cancers Symposium
January 31, 2023
Subset of Patients With Advanced Gastric/GEJ Cancer May Benefit From CLDN18.2-Targeted Drug Zolbetuximab: SPOTLIGHT Study
2023 ASCO Gastrointestinal Cancers Symposium
January 31, 2023
How Experts Treat Mantle Cell Lymphoma in First Complete Response
2022 Pan Pacific Lymphoma Conference
January 25, 2023
SERENA-2 Trial: Camizestrant Improves Progression-Free Survival in Advanced Breast Cancer
2022 San Antonio Breast Cancer Symposium
January 25, 2023
Cabozantinib Plus Atezolizumab Warrants Further Study in Treatment of Advanced Head and Neck Cancer
SITC 2022
January 25, 2023
Study Finds Immune Checkpoint Inhibitors Safe and Effective for Patients Living With HIV Who Have NSCLC
SITC 2022
January 25, 2022
PI3K Pathway Activation May Underlie Tamoxifen-Associated Uterine Cancer
2021 San Antonio Breast Cancer Symposium
January 04, 2022
Identifying Women With Triple-Negative Breast Cancer Who May Benefit From Pembrolizumab Plus Chemotherapy
2021 San Antonio Breast Cancer Symposium
December 21, 2021
Expert Point of View: Matthew J. Ellis, MB, BChir, PhD, FACP
2021 San Antonio Breast Cancer Symposium
December 21, 2021
Composite Biomarker Needed to Predict Benefit of Immunotherapy in Triple-Negative Breast Cancer
2021 Lynn Sage Breast Cancer Symposium
November 10, 2021
Many Patients With Solid Tumors Mount an Adequate Response to SARS–CoV-2 Vaccine, Dutch Study Reports
ESMO Congress 2021
October 13, 2021
Novel HER2-Targeted Therapies Pose Sequencing Challenges
38th Annual Miami Breast Cancer Conference
October 13, 2021
Neoadjuvant Durvalumab Improves Long-Term Outcomes in the GeparNuevo Trial
2021 ASCO Annual Meeting
October 10, 2021
Benefits Seen With Lurbinectedin Plus Doxorubicin in Small Cell Lung Cancer—but Primary Endpoint Missed
IASLC 2021 World Conference on Lung Cancer
September 24, 2021
BRAF-Mutant Colorectal Cancer: Latest Findings for Targeted Treatment
ESMO World Congress on Gastrointestinal Cancer 2021
September 16, 2021
CheckMate 648: First-Line Nivolumab Regimens Improve Survival in Esophageal Squamous Cell Carcinoma
2021 ASCO Annual Meeting
September 10, 2021
Safety, Efficacy of Neoadjuvant Pertuzumab Plus Trastuzumab Maintained in Final Analysis of BERENICE Trial
ESMO Breast Cancer Virtual Congress 2021
September 01, 2021
Neoadjuvant Durvalumab Improves Long-Term Outcomes in the GeparNuevo Trial
2021 ASCO Annual Meeting
August 16, 2021
Phase III GLOW Trial: Improved Outcomes With First-Line Ibrutinib Plus Venetoclax in Elderly Patients With CLL
EHA 2021 Virtual Congress
August 16, 2021
Zanubrutinib Superior to Ibrutinib for CLL/SLL in Phase III ALPINE Trial
EHA 2021 Virtual Congress
July 26, 2021
Lessons From the Pandemic: How COVID-19 Can Lead to Improvements in Cancer Care
NCCN Virtual Oncology Policy Summit
June 11, 2021
Adjuvant Imatinib Therapy Offers Survival Benefit in Patients With Resected GIST, but Team Effort May Be Needed to Reduce Early Discontinuation Rates
SSO 2021 International Conference on Surgical Cancer Care
June 10, 2021
Global Responses to COVID-19 Pandemic–Related Disruptions in Cancer Care
SSO 2021 International Conference on Surgical Cancer Care
June 10, 2021
Actionable Mutations Identified in Majority of Genome-Sequenced Resected Cholangiocarcinomas
SSO 2021 International Conference on Surgical Cancer Care
June 10, 2021
Expert Point of View: Thomas Herzog, MD
SGO 2021 Virtual Annual Meeting on Womens Cancer
June 10, 2021
Could Risk-Based Triage System Alter Surgical Practice in Ovarian Cancer?
SGO 2021 Virtual Annual Meeting on Womens Cancer
June 10, 2021
New Approaches Needed for Patients With Locoregional Breast Cancer Progression During Neoadjuvant Systemic Therapy
22nd ASBrS Annual Meeting
June 10, 2021
Selected Poster Presentations From the NCCN 2021 Annual Conference
NCCN 2021 Virtual Annual Conference
May 27, 2021
2021 Genitourinary Cancers Symposium: Advancements in the Care of Older Adults With Prostate Cancer
2021 Genitourinary Cancers Symposium
May 27, 2021
Single-Agent Pembrolizumab Yields High Response Rates in Patients With Cutaneous Squamous Cell Carcinoma
AACR Annual Meeting 2021
May 25, 2021
Study Finds Ixabepilone Plus Bevacizumab Active in Platinum-Resistant or Recurrent Ovarian Cancer
SGO 2021 Virtual Annual Meeting on Womens Cancer
May 25, 2021
Dual BRAF/MEK Inhibition Under Study in BRAF V600E–Mutant Gliomas
AACR Annual Meeting 2021
May 25, 2021
NCCN Clinical Practice Guidelines in Oncology: 2021 Updates
NCCN 2021 Virtual Annual Conference
April 21, 2021
First-Line Nivolumab Plus Cabozantinib Improves Outcomes vs Sunitinib in Advanced Renal Cell Carcinoma
ESMO Virtual Congress 2020
April 21, 2021
Adding Apalutamide to Abiraterone/Prednisone Extends Radiographic Progression-Free but Not Overall Survival
2021 Genitourinary Cancers Symposium
April 09, 2021
Cardiovascular Risks Associated With Checkpoint Inhibitors and CAR T-Cell Therapy
2021 ACC Conference on Advancing the Cardiovascular Care of the Oncology Patient
March 18, 2021
Oncologist Survey Identifies Knowledge Gaps in Cholangiocarcinoma Mutations
2021 Gastrointestinal Cancers Symposium
March 10, 2021
Novel Therapies Under Study in Chronic Myeloid Leukemia
2020 ASH Annual Meeting & Exposition
March 10, 2021
In Cholangiocarcinoma, Does Chemotherapy Response Vary According to FGFR2 Status?
2021 Gastrointestinal Cancers Symposium
March 10, 2021
Fallout From COVID-19: Decline in Cancer Screening and Increase in Cancer-Related Deaths
AACR Virtual Meeting: COVID-19 and Cancer 2021
February 25, 2021
SIMPLIFY Trials: JAK Inhibitor Yields Long-Term Survival Benefit and Transfusion Independence in Myelofibrosis
2020 ASH Annual Meeting & Exposition
February 10, 2021
Severity of Patients’ Symptoms May Be Underrecognized During and After Breast Radiotherapy
2020 San Antonio Breast Cancer Symposium
February 10, 2021
Expert Point of View: Virginia Kaklamani, MD
2020 San Antonio Breast Cancer Symposium
February 10, 2021
Anti–PD-1 Antibody Dostarlimab Active in Mismatch Repair–Deficient Gastrointestinal Tumors
2021 Gastrointestinal Cancers Symposium
January 25, 2021
A Tale of Two CDK4/6 Inhibitors in Early Breast Cancer
2020 San Antonio Breast Cancer Symposium
January 25, 2021
Oral Azacitidine Is Noninferior to Placebo for Health-Related Quality of Life in AML
2020 ASH Annual Meeting & Exposition